NASDAQ:MRVI
Maravai LifeSciences Holdings, Inc.
- Stock
Last Close
9.21
30/08 20:00
Market Cap
1.03B
Beta: −0.23
Volume Today
1.14M
Avg: 1.43M
PE Ratio
9.61
PFCF: 8.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 14.26M - | 23.75M 66.62% | 42.43M 78.64% | 47.35M 11.61% | 47.27M 0.17% | ||
average payables | 5.54M - | 7.82M 41.21% | 8.16M 4.32% | 7.07M 13.35% | 8.36M 18.20% | ||
average receivables | 17.01M - | 34.52M 102.96% | 84.27M 144.08% | 132.16M 56.84% | 104.80M 20.70% | ||
book value per share | 1.62 - | 1.59 2.08% | 8.55 438.02% | 2.75 67.86% | 4.14 50.80% | 3.16 23.78% | |
capex per share | -0.04 - | -0.19 374.88% | -2.45 1,173.49% | -0.13 94.73% | -0.13 0.43% | ||
capex to depreciation | -0.16 - | -0.71 340.63% | -0.98 38.12% | -0.60 38.99% | -0.45 25.24% | ||
capex to operating cash flow | 19.41 - | -0.71 103.66% | -0.17 76.52% | -0.04 75.87% | -0.03 20.86% | ||
capex to revenue | -0.03 - | -0.12 310.83% | -0.09 25.35% | -0.02 79.22% | -0.02 4.17% | ||
cash per share | 0.25 - | 0.28 12.96% | 22.82 8,118.52% | 4.80 78.95% | 4.81 0.06% | 4.36 9.30% | |
days of inventory on hand | 85.94 - | 77.54 9.77% | 152.61 96.80% | 133.88 12.27% | 93.22 30.37% | 126.12 35.29% | |
days payables outstanding | 21.65 - | 40.83 88.61% | 37.44 8.29% | 21.17 43.45% | 12.94 38.88% | 26.33 103.42% | |
days sales outstanding | 47.13 - | 45.98 2.46% | 65.55 42.57% | 53.67 18.13% | 60.69 13.08% | 79.32 30.70% | |
debt to assets | 0.63 - | 0.68 7.23% | 0.46 31.16% | 0.28 40.09% | 0.26 7.94% | 0.37 45.94% | |
debt to equity | 2.35 - | 2.76 17.25% | 6.67 141.87% | 1.69 74.63% | 1.07 36.62% | 1.34 24.44% | |
dividend yield | 0.02 - | 2.10 - | |||||
earnings yield | -0.01 - | -0.00 70.67% | 0.31 15,746.53% | 0.10 68.16% | 0.26 167.17% | -0.14 152.85% | |
enterprise value | 2.97B - | 3.02B 1.60% | 644.94M 78.65% | 4.79B 643.13% | 1.84B 61.70% | 845.78M 53.92% | |
enterprise value over ebitda | 74.70 - | 62.28 16.63% | 6.90 88.92% | 8.82 27.71% | 3.23 63.37% | -26.72 927.57% | |
ev to operating cash flow | -15.99K - | 125.28 100.78% | 4.24 96.62% | 13.00 206.85% | 3.42 73.66% | -283.16 8,368.15% | |
ev to sales | 24.01 - | 21.11 12.11% | 2.27 89.24% | 6.00 164.15% | 2.08 65.34% | 2.93 40.81% | |
free cash flow per share | -0.04 - | 0.08 283.49% | 12.25 15,540.18% | 3.08 74.84% | 3.94 28.01% | -0.02 100.57% | |
free cash flow yield | -0.00 - | 0.00 283.49% | 0.44 16,543.82% | 0.07 83.16% | 0.28 274.82% | -0.00 101.25% | |
graham net net | -3.94 - | -4.36 10.61% | -79.69 1,727.91% | -6.17 92.26% | -4.66 24.39% | -0.38 91.90% | |
graham number | 2.70 - | 1.45 46.41% | 40.67 2,712.57% | 15.90 60.90% | 18.65 17.30% | 8.01 57.06% | |
income quality | 0.01 - | -4.64 42,265.72% | 1.93 141.64% | 0.79 59.32% | 1.09 39.07% | 1 8.45% | |
intangibles to total assets | 0.82 - | 0.73 10.88% | 0.32 56.70% | 0.14 55.45% | 0.22 55.56% | 0.37 67.76% | |
interest coverage | 0.60 - | 0.80 33.48% | 2.20 174.64% | 18.33 733.53% | 28.13 53.46% | 0.69 97.55% | |
interest debt per share | 4.13 - | 4.72 14.40% | 60.04 1,171.39% | 4.92 91.81% | 4.60 6.38% | 3.87 15.91% | |
inventory turnover | 4.25 - | 4.71 10.83% | 2.39 49.19% | 2.73 13.99% | 3.92 43.61% | 2.89 26.09% | |
invested capital | 2.35 - | 2.76 17.25% | 6.67 141.87% | 1.69 74.63% | 1.07 36.62% | 1.34 24.44% | |
market cap | 2.66B - | 2.66B 0% | 290.35M 89.07% | 4.81B 1,556.56% | 1.88B 60.86% | 864.07M 54.10% | |
net current asset value | -337.86M - | -372.62M 10.29% | -784.35M 110.50% | -632.88M 19.31% | -529.17M 16.39% | 2.35M 100.44% | |
net debt to ebitda | 7.99 - | 7.53 5.69% | 3.80 49.63% | -0.03 100.82% | -0.08 164.39% | 0.58 800.57% | |
net income per share | -0.20 - | -0.06 70.67% | 8.60 14,803.02% | 4.09 52.44% | 3.73 8.75% | -0.90 124.19% | |
operating cash flow per share | -0.00 - | 0.27 13,065.05% | 14.70 5,324.13% | 3.21 78.16% | 4.07 26.90% | -0.02 100.56% | |
payables turnover | 16.86 - | 8.94 46.98% | 9.75 9.04% | 17.24 76.84% | 28.20 63.60% | 13.86 50.84% | |
receivables turnover | 7.74 - | 7.94 2.52% | 5.57 29.86% | 6.80 22.14% | 6.01 11.57% | 4.60 23.49% | |
research and ddevelopement to revenue | 0.04 - | 0.03 30.26% | 0.03 29.25% | 0.02 41.86% | 0.02 9.25% | 0.06 187.48% | |
return on tangible assets | -0.18 - | -0.03 81.67% | 0.10 406.53% | 0.28 178.04% | 0.28 3.30% | -0.13 145.97% | |
revenue per share | 1.39 - | 1.61 15.59% | 27.45 1,605.88% | 6.96 74.63% | 6.71 3.59% | 2.19 67.37% | |
roe | -0.12 - | -0.04 70.04% | 1.01 2,832.79% | 1.49 47.96% | 0.90 39.49% | -0.29 131.74% | |
roic | 0.03 - | 0.04 5.20% | 0.09 143.15% | 0.57 547.91% | 0.43 25.16% | 0.01 98.36% | |
sales general and administrative to revenue | 0.33 - | ||||||
shareholders equity per share | 1.62 - | 1.59 2.08% | 8.55 438.02% | 2.75 67.86% | 4.14 50.80% | 3.16 23.78% | |
stock based compensation to revenue | 0.02 - | 0.01 31.52% | 0.09 639.08% | 0.01 84.91% | 0.02 61.59% | ||
tangible asset value | -294.39M - | -277.50M 5.74% | -247.19M 10.92% | 275.02M 211.26% | 404.91M 47.23% | 242.87M 40.02% | |
tangible book value per share | -3.31 - | -3.12 5.74% | -23.88 665.59% | 2.40 110.03% | 3.08 28.48% | 1.84 40.19% | |
working capital | 17.88M - | 30.99M 73.29% | 200.82M 548.02% | 646.26M 221.81% | 737.76M 14.16% | 612.44M 16.99% |
All numbers in USD (except ratios and percentages)